Abstract: An evaporator body for a PVD coating system comprises a basic body and an evaporator surface, to which a titanium dihydride layer is applied. A titanium hydride layer comprises an organic carrier agent and titanium hydride as the single inorganic solid. The thickness of the layer is less than or equal to 10 ?m.

Abstract: A vaporizer body (1) having a vaporizing surface (3) for vaporizing metal in a PVD-metallization installation, wherein the vaporizing surface (3) comprises a plurality of recesses (5, 5?, 5?), with an opening of the respective recess having an area/perimeter-ratio of greater than or equal to 1.5 mm.

Abstract: An evaporator body for a PVD coating system comprises a basic body and an evaporator surface, to which a titanium dihydride layer is applied. A titanium hydride layer comprises an organic carrier agent and titanium hydride as the single inorganic solid. The thickness of the layer is less than or equal to 10 ?m.

Abstract: An evaporator body for a PVD coating system comprises a basic body and an evaporator surface, to which a titanium dihydride layer is applied. A titanium hydride layer comprises an organic carrier agent and titanium hydride as the single inorganic solid. The thickness of the layer is less than or equal to 10 ?m.

Abstract: A vaporizer body (1) having a vaporizing surface (3) for vaporizing metal in a PVD-metallization installation, wherein the vaporizing surface (3) comprises a plurality of recesses (5, 5?, 5?), with an opening of the respective recess having an area/perimeter-ratio of greater than or equal to 1.5 mm.

Abstract: An evaporator body for a PVD coating system comprises a basic body and an evaporator surface, to which a titanium dihydride layer is applied. A titanium hydride layer comprises an organic carrier agent and titanium hydride as the single inorganic solid. The thickness of the layer is less than or equal to 10 ?m.

Abstract: In order to ensure that metal is homogeneously vaporized, in particular in a vacuum-strip vaporizer plant, a vaporization unit (2) is provided which has an inner cavity (6) which is defined by a circumferential web (10) to which an outer cavity (8) is connected.

Abstract: Methods for generating and using omentum cells, and particularly stromal cells and/or omentum stem cells, in medical treatments such as tissue repair and regeneration to facilitate healing from traumatic injury to an abdominal organ, and immune modulation treatments such as suppression of immune responses and inflammation and prevention of tissue fibrosis. According to one aspect, a medical procedure is performed on a patient that involves harvesting omental tissue from the patient, and then transferring the omental tissue to an organ of the patient. At least a portion of the harvested omental tissue may be activated prior to transferring the omental tissue to the organ. Alternatively, the transferred omental tissue may comprise non-lymphoid cells isolated from the omentum tissue and obtained by homogenizing at least a portion of the harvested omental tissue.

Abstract: A Brassica plant comprising a unique recombination event resulting from a break at a position along a nucleic acid segment derived from Ogura Raphanus sativus between the restorer locus and the glucosinolate locus and subsequent rejoining to produce a new recombination event, BLR1. The BLR1 recombination event expresses fertility restoring resulting from expression of the restorer gene derived from Raphanus sativus and a GSL content no higher than normal double low open pollinated varieties. The Brassica inbred line BLR-038, Deposit Number NCIMB-41193, is one example of a plant that contains the BLR1 recombination event. The BLR1 recombination event is introgressed into different Brassica genetic backgrounds using breeding techniques known to those skilled in the art. For example, the Brassica inbred line BLR-038 or another Brassica plant containing the BLR1 recombination event may be crossed with male sterile inbreds to produce hybrids expressing low GSL content and superior agronomic traits.

Abstract: A Brassica plant comprising a unique recombination event resulting from a break at a position along a nucleic acid segment derived from Ogura Raphanus sativus between the restorer locus and the glucosinolate locus and subsequent rejoining to produce a new recombination event, BLR1. The BLR1 recombination event expresses fertility restoring resulting from expression of the restorer gene derived from Raphanus sativus and a GSL content no higher than normal double low open pollinated varieties. The Brassica inbred line BLR-038, Deposit Number NCIMB-41193, is one example of a plant that contains the BLR1 recombination event. The BLR1 recombination event is introgressed into different Brassica genetic backgrounds using breeding techniques known to those skilled in the art. For example, the Brassica inbred line BLR-038 or another Brassica plant containing the BLR1 recombination event may be crossed with male sterile inbreds to produce hybrids expressing low GSL content and superior agronomic traits.

Abstract: A Brassica plant comprising a unique recombination event resulting from a break at a position along a nucleic acid segment derived from ogura Raphanus sativus between the restorer locus and the glucosinolate locus and subsequent rejoining to produce a new recombination event, BLR1. The BLR1 recombination event expresses fertility restoring resulting from expression of the restorer gene derived from Raphanus sativus and a GSL content no higher than normal double low open pollinated varieties. The Brassica inbred line BLR-038, Deposit Number NCIMB-41193, is one example of a plant that contains the BLR1 recombination event. The BLR1 recombination event is introgressed into different Brassica genetic backgrounds using breeding techniques known to those skilled in the art. For example, the Brassica inbred line BLR-038 or another Brassica plant containing the BLR1 recombination event may be crossed with male sterile inbreds to produce hybrids expressing low GSL content and superior agronomic traits.

Abstract: Methods for generating and using omentum cells, and particularly stromal cells and/or omentum stem cells, in medical treatments such as tissue repair and regeneration to facilitate healing from traumatic injury to an abdominal organ, and immune modulation treatments such as suppression of immune responses and inflammation and prevention of tissue fibrosis. According to one aspect, a medical procedure is performed on a patient that involves harvesting omental tissue from the patient, and then transferring the omental tissue to an organ of the patient. At least a portion of the harvested omental tissue may be activated prior to transferring the omental tissue to the organ. Alternatively, the transferred omental tissue may comprise non-lymphoid cells isolated from the omentum tissue and obtained by homogenizing at least a portion of the harvested omental tissue.

Abstract: A Brassica plant comprising a unique recombination event resulting from a break at a position along a nucleic acid segment derived from ogura Raphanus sativus between the restorer locus and the glucosinolate locus and subsequent rejoining to produce a new recombination event, BLR1. The BLR1 recombination event expresses fertility restoring resulting from expression of the restorer gene derived from Raphanus sativus and a GSL content no higher than normal double low open pollinated varieties. The Brassica inbred line BLR-038, Deposit Number NCIMB-41193, is one example of a plant that contains the BLR1 recombination event. The BLR1 recombination event is introgressed into different Brassica genetic backgrounds using breeding techniques known to those skilled in the art. For example, the Brassica inbred line BLR-038 or another Brassica plant containing the BLR1 recombination event may be crossed with male sterile inbreds to produce hybrids expressing low GSL content and superior agronomic traits.

Abstract: A synthesis member preferably comprises two elements: a crown and a stem. The stem includes a tag, such as a transponder, that is used to identify the synthesis member and/or the synthetic history of the synthesis member when used in the automated synthesis of compound libraries containing large numbers (e.g. 1000 or more) compounds. The crown provides the location at which compounds are synthesized. The combination of a crown for use with compound synthesis and stem allows the tracking of individual synthesis members from a library containing thousands of such synthesis members. Because each synthesis member is individually tracked and can be logged into a database and/or process flow control system, the synthesis of several thousand individual compounds in conventional containers, such as round bottom flasks is made possible using only traditional compound synthesis approaches.

Abstract: Compounds of formula I, ##STR1## wherein R.sub.1 to R.sub.4 possess the significances given in the description, may be used in the treatment of senile dementia, Alzheimer's disease and depression.

Abstract: Printing control element for detecting color register deviations in a defined direction, the printing control element being disposed in a selected region on a printed product produced by a printing press and scannable by a single opto-electronic sensor device, includes a plurality of equidistant geometric figures disposed adjacent one another in a row without gaps therebetween in the defined direction when a print is in-register, every third one of the adjacent geometric figures being in a set color and, respectively, in the defined direction, one of the geometric figures in another color being disposed adjoining the third geometric figure; and a method of regulating color register.

Abstract: Offset printing method wherein ink in the form of screened half-tone dots or pixels and unscreened printing-image elements is applied to a printing surface of a recording medium by means of a printing device; a printing form being generated from signals reproducing a printed image; the printing form being inked with an inking device; and the ink being transferred to the printing surface, upon transport of the recording medium relative to the printing device; the signals being processed in a control device for the printing device; includes, near the printing device and before the printing form is generated on a screen or monitor, forming a copy of the printed image from the signals reproducing the printed image and from signals containing parameters of the printing device; whenever the copy deviates from a desired printed image, manually inputting correction values for local inking into the control device, until the copy corresponds to the desired printed image; and generating the printing form and adjusting t

Abstract: Cyanoisoxazoles of the formula Ia or Ib ##STR1## where R.sup.1 is hydrogen, alkyl, cycloalkyl, phenyl; R.sup.2 is hydrogen, alkyl, cycloalkyl and R.sup.3 is alkoxy, alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl or phenyl, it being possible for the organic radicals mentioned under R.sup.1, R.sup.2 and R.sup.3 to be substituted in each case. The compounds of the Formula Ia or Ib are useful as herbicides.

Abstract: 2-substituted 2,3-epoxy-5-cyclohexenone derivatives of the formula I ##STR1## where W is C.dbd.O or CHOR.sup.1, R.sup.1 is hydrogen, alkyl, alkenyl, alkynyl or alkoxycarbonyl, R is a substituted or unsubstituted hydrocarbon chain, or phenyl or phenylalkyl whose phenyl radical is substituted or unsubstituted and whose alkyl radical may be interrupted by O or S and fungicides and herbicides containing these compounds.

Abstract: Substituted benzofuran derivatives of the formula ##STR1## where R.sup.1, R.sup.2 and R.sup.3 are hydrogen, an alkali or alkaline earth metal, alkyl, aralkyl, alkanoyl, halogen-substituted alkanoyl, benzoyl or a radical R.sup.4 R.sup.5 R.sup.6 Si in which R.sup.4, R.sup.5 and R.sup.6 are alkyl, and fungicides containing these compounds.